# CABTREO
> **NDA216632** · New Drug Application · Sponsor: BAUSCH · Approved 2023-10-20
## Drug
- **FDA Application Number:** NDA216632
- **Application type:** New Drug Application
- **Brand name:** CABTREO
- **Generic name:** CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE
- **Active ingredients:** ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH
- **Manufacturer:** Bausch Health US LLC
- **First approval:** 2023-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216632)
---
*AI Analytics · CC0 1.0*